Article PDF
Avoid common mistakes on your manuscript.
References
Aisen, RS.; Davis, K.L.; Berg, J.D.; Schafer, K.; Campbell, K.; Thomas, R.G.; Weiner, M.F.; Farlow, M.R.; Sano, M.; Grundman, M.; Thal, L.J. (2000). A Randomized Controlled Trial of Prednisone in Alzheimer’s Disease. Alzheimer’s Disease Cooperative Study. Neurology, 54(3), 588–593.
Bard, E; Cannon, C.; Barbour, R.; Burke, R.L.; Games, D.; Grajeda, H.; Guide, T.; Hu, K.; Huang, J.; Johnson-Wood, K.; Khan, K.; Kholodenko, D.; Lee, M.; Lieberburg, L; Motter, R.; Nguyen, M.; Soriano, E; Vasquez, N.; Weiss, K.; Welch, B.; Suebert, P.; Schenk, D.; Yednock, T. (2000). Peripherally Administered Antibodies Against Amyloid b-peptide Enter the Central Nervous System and Reduce Pathology in a Mouse Model of Alzheimer Disease. Nature Medicine, 6(8), 916–919.
Benveniste, H.; Einstein, G.; Kim, K.R.; Hulette, C.; Johnson, G.A. (1999). Detection of Neuritic Plaques in Alzheimer’s Disease by Magnetic Resonance Microscopy. Proceedings of the National Academy of Sciences USA, 96(24), 14079–14084.
Bickford, P.C.; Gould, T.; Briederick, L.; Chadman, K.; Pollock, A.; Young, D.; Shukitt-Hale, B.; Joseph, J. (2000). Antioxidant-rich Diets Improve Cerebellar Physiology and Motor Learning in Aged Rats. Brain Research, 866(1–2), 211–217.
Blacker, D.; Crystal, A.S.; Wilcox, M.A.; Laird, N.M.; Tanzi, R.E. (1999). Alpha-2 Macroglobulin Gene and Alzheimer’s Disease. Nature Genetics, 22, 16–17.
Brookmeyer, R.; Gray, S.; Kawas, C. (1998). Projections of Alzheimer’s Disease in the United States and the Public Health Impact of Delaying Disease Onset. American Journal of Public Health, 88(9), 1337–1342.
Bruccoleri, A.; Harry, G.J. (2000). Chemical-induced Hippocampal Neurodegeneration and Elevations in TNFalpha, TNFb, IL-1 alpha, IP-10, and MCP-1 mRNA in Osteopetrotic (op/op) Mice. Journal of Neuroscience Research, 62(1), 146–155.
Bruccoleri, A.; Pennypacker, K.R.; Harry, G.F. (1999). Effect of Dexamethasone on Elevated Cytokine mRNA Levels in Chemical-induced Hippocampal Injury. Journal of Neuroscience Research, 57(6), 916–926.
Campbell, A.; Kumar, A.; La Rosa, F.G.; Prasad, K.N.; Bondy, S.C. (2000). Aluminum Increases Levels of Beta-amyloid and Ubiquitin in Neuroblastoma But Not in Glioma Cells. Proceedings of the Society of Experimental Biology and Medicine, 223(4), 397–402.
Convit, A.; de Asis, J.; de Leon, M.J.; Tarshish, C.Y.; De Santi, S.; Rusinek, H. (2000). Atrophy of the Medial Occipitotemporal, Inferior and Middle Temporal Gyri in Non-demented Elderly Predict Decline to Alzheimer’s Disease. Neurobiology of Aging, 21(1), 19–26.
Daly, E.; Zaitchik, D.; Copeland, M.; Schmahmann, L; Gunther, J.; Albert, M. (2000). Predicting Conversion to Alzheimer Disease Using Standardized Clinical Information. Archives of Neurology, 57(5), 675–680.
Dodel, R.C.; Du, Y; Bales, K.R.; Gao, F; Eastwood, B.; Glazier, B.; Zimmer, R.; Cordell, B.; Hake, A.; Evans, R.; Gallagher-Thompson, D.; Thompson, L.W.; Tinklenberg, J.R.; Pfefferbaum, A.; Sullivan, E.V.; Yesavage, J.; Astiel, L.; Gasser, T.; Farlow, M.R.; Murphy, G.M.; Paul, S.M. (2000). Alpha-2 Macroglobulin and the Risk of Alzheimer’s Disease. Neurology, 54(2), 438–442.
Earnst, K.S.; Marson, D.C.; Harrell, L.E. (2000). Cognitive Models of Physicians’ Legal Standard and Personal Judgments of Competency in Patients with Alzheimer’s Disease. Journal of the American Geriatrics Society, 48(8), 919–927.
Ernst, R.L.; Hay, J.W. (1994). The U.S. Economic and Social Costs of Alzheimer’s Disease Revisited. American Journal of Public Health, 84(8), 1261–1264.
Ernst, R.L.; Hay, J.W.; Fenn, C.; Tinklenberg, J.; Yesavage, J.A. (1997). Cognitive Function and the Costs of Alzheimer’s Disease. An Exploratory Study. Archives of Neurology, 54(6), 687–693.
Esler, W.P.; Kimberly, W.T.; Ostaszewski, B.L.; Diehl, T.S.; Moore, C.L.; Tsai, J.Y.; Rahmati, T.; Xia, W.; Selkoe, D.J.; Wolfe, M.S. (2000). Transition -state Analogue Inhibitors of Gammasecretase Bind Directly to Presenilin-1. Nature Cell Biology, 2(7), 428–434.
Evans, D.A.; Funkenstein, H.H.; Albert, M.S.; Scherr, P.A.; Cook, N.R.; Chown, M.J.; Herbert, L.E.; Hennekens, C.H.; Taylor, J.O. (1989). Prevalence of Alzheimer’s Disease in a Community Population of Older Persons. Higher Than Previously Reported. JAMA, 262(18), 2551–2556.
Evans, R.M.; Emsely, C.L.; Gao, S.; Sahota, A.; Hall, K.S.; Farlow, M.R.; Hendrie, H. (2000). Serum Cholesterol, APOE Genotype, and the Risk of Alzheimer’s Disease: A Population-based Study of African Americans. Neurology, 54(1), 240–242.
Faller, P.; Hasler, D.W.; Zerbe, O.; Klauser, S.; Winge, D.R.; Vasak, M. (1999). Evidence for a Dynamic Structure of Human Neuronal Growth Inhibitory Factor and for Major Rearrangements of Its Metal-thiolate Clusters. Biochemistry, 38(3 1), 10158–10167.
Fillenbaum, G.G.; Heyman, A.; Huber, M.S.; Woodbury, M.A.; Leiss, J.; Schmader, K.E.; Bohannon, A.; Trapp-Moen, B. (1998). The Prevalence and 3-Year Incidence of Dementia in Older Black and White Community Residents. Journal of Clinical Epidemiology, 51(7), 587–595.
Fox, N.C.; Cousens, S.; Scahill, R.; Harvey, R.J.; Rossor, M.N. (2000). Using Serial Registered Brain Magnetic Resonance Imaging to Measure Disease Progression in Alzheimer Disease. Archives of Neurology, 57(3), 339–344.
Georgakopoulos, A.; Marambaud, P.; Efthimiopoulos, S.; Shioi, J.; Cui, W.; Li, H.C.; Schutte, M.; Gordon, R.; Holstein, G.R.; Martinelli, G.; Mehta, P.; Friedrich, V.L.; Robakis, M.K. (1999). Presenilin- I Forms Complexes With Cadherin/Catenin Cell-Cell Adhesion System and Is Recruited to Intercellular and Synaptic Contacts. Molecular Cell, 4(6), 893–902.
Gitlin, L.N.; Corcoran, M. (2000). Making Homes Safer: Environmental Adaptations for People with Dementia. Alzheimer’s Care Quarterly, 1, 50–58.
Gitlin, L.N.; Corcoran, M.; Winter, L.; Boyce, A.; Marcus, S. (1999). Predicting Participation and Adherence to a Home Environmental Intervention Among Family Caregivers of Persons with Dementia. Family Relations, 48, 363–372.
Gouras, G.K.; Xu, H.; Gross, R.S.; Greenfield, J.P.; Hai, B.; Wang, R.; Greengard, P. (2000). Testosterone Reduces Neuronal Secretion of Alzheimer’s B-amyloid Peptides. Proceedings of the National Academy of Sciences USA, 97(3), 1202–1205.
Graves, A.B.: Bowen, J.D.; Rajaram, L.: McCormick, W.C.; McCurry, S.M.; Schellenberg, G.D.; Larson, E.B. (1999). Impaired Olfaction as a Marker for Cognitive Decline: Interaction With Apolipoprotein E Epsilon4 Status. Neurology, 53(7), 1480–1487.
Green, M.S.; Kaye, J.A.; Ball, M.J. (2000). The Oregon Brain Aging Study: Neuropathology Accompanying Healthy Aging in the Oldest Old. Neurology, 54(1), 105–113.
Guo, Z.; Cupples, L.A.; Kurz, A.; Auerbach, S.H.; Volicer, L.; Chui, H.; Green, R.C.; Sadovnick, A.D.; Duara, R.; DeCarli, C.; Johnson, K.; Go, R.C.; Growdon, J.H.; Haines, J.L.; Kukull, W.A.; Farrer, L.A. (2000). Head Injury and the Risk of AD in the MIRAGE Study. Neurology, 54(6), 1316–1323.
Guo-Ross, S.X.; Yang, E.Y.; Walsh, T.J.; Bondy, S.C. (1999). Decrease of Glial Fibrillary Acidic Protein in Rat Frontal Cortex Following Aluminum Treatment. Journal of Neurochemistry, 73(4). 1609–1614.
Hall, K.S.; Gao, S.; Unverzagt, F.W.; Hendrie, H.C. (2000). Low Education and Childhood Rural Residence: Risk for Alzheimer’s Disease in African Americans. Neurology, 54(1), 95–99.
Harry, G.J.; Lefebvre d’Hellencourt, C.; Bruccoleri, A.; Schmechel, D. (2000). Age Dependent Cytokine Responses: Trimethyltin Hippocampal Injury in Wildtype, APOE Knockout, and APOE4 Mice. Brain Behavior and Immunity, 14(4), 288–304.
Hatanpää, K.; Isaacs, K.R.; Shirao, T.; Brady, D.R.; Rapoport, S.I. (1999). Loss of Proteins Regulating Synaptic Plasticity in Normal Aging of the Human Brain and in Alzheimer Disease. Journal of Neuropathology and Experimental Neurology, 58(6), 637–643.
Helmuth, L. (2000). Alzheimer’s Congress. Further Progress on a 6-Amyloid Vaccine. Science, 289(5476), 375.
Henderson, V.W.; Paganini-Hill, A.; Miller, B.L.; Elble, R.J.; Reyes, RE; Shoupe, D.; McCleary, C.A.; Klein, R.A.; Hake, A.M.; Farlow, M.R. (2000). Estrogen for Alzheimer’s Disease in Women: Randomized, Double-blind, Placebo-controlled Trial. Neurology, 54(2), 295–301.
Holtzman, D.M.; Bales, K.R.; Tendova, T.; Fagan, A.M.; Parsadanian, M.A.; Sartorius, L.J.; Mackey, B.; Olney, J.; McKeel, D.; Wozniak, D.; Paul, S.M. (2000). Apolipoprotein E Isoform-dependent Amyloid Deposition and Neuritic Degeneration in a Mouse Model of Alzheimer’s Disease. Proceedings of the National Academy of Sciences USA, 97(6), 2892–2897.
Huang, L.F.; Cartwright, W.S.; Hu, T.W. (1988). The Economic Cost of Senile Dementia in the United States, 1985. Public Health Reports, 103(1), 3–7.
Hussain, L; Powell, D.; Howlett, DR.; Tew, D.G.; Meek, T.D.; Chapman, C.; Gloger, I.S.; Murphy, K.E.; Southan, C.D.; Ryan, D.M.; Smith, T.S.; Simmons, D.L.; Walsh, F.S.; Dingwall, C.; Christie, G. (1999). Identification of a Novel Aspartic Protease (Asp 2) as B-secretase. Molecular and Cellular Neuroscience, 14(6), 419–427.
Ishihara, T.; Hong, M.; Zhang, B.; Nakagawa, Y.; Lee, M.K.; Trojanowski, J.Q.; Lee, V.M. (1999). Age-dependent Emergence and Progression of a Tauopathy in Transgenic Mice Overexpressing the Shortest Human Tau Isoform. Neuron, 24(3), 751–762.
Jeste, D.V; Lacro, J.P.; Palmer, B.; Rockwell, E.; Harris, M.J.; Caliguiri, M.P. (1999). Incidence of Tardive Dyskinesia in Early Stages of Low-dose Treatment with Typical Neuroleptics in Older Patients. American Journal of Psychiatry, 156(2), 309–311.
Jeste, D.V.; Lacro, J.P.; Bailey, A.; Rockwell, E.; Harris, M.J.; Caligiuri, M.P. (1999). Lower Incidence of Tardive Dyskinesia with Risperidone Compared with Haloperidol in Older Patients. Journal of the American Geriatrics Society, 47(6), 716–719.
Kahle, P.; Jakowec, M.; Teipel, S.J.; Hampel, H.; Petzinger, G.M.; Di Monte, D.; Silverberg, G.D.; Yesavage, J.A.; Moller, H.J.; Tinklenberg, JR.; Shooter, E.M.; Murphy, G.M. (2000). Combined Assessment of Tau and Neuronal Thread Protein in Alzheimer’s Disease Cerebrospinal Fluid. Neurology, 54(7), 1498–1504.
Killiany, R.J.; Gomez-Isla, T.; Moss, M.; Kikinis, R.; Sandor, T.; Jolesz, F.; Tanzi, R.; Jones, K.; Hyman, B.; Albert, M. (2000). Use of Structural Magnetic Resonance Imaging to Predict Who Will Get Alzheimer’s Disease. Annals of Neurology, 47(4), 430–439.
Kim, S.H.; Wang, R.; Gordon, D.J.; Bass, J.; Steiner, D.F.; Lynn, D.G.; Thinakaran, G.; Meredith, S.C.; Sisodia, S.S. (1999). Form Mediates Enhanced Production of Fibrillogenic ABri Peptides in Familial British Dementia. Nature Neuroscience, 2(11), 984–988.
Kimberly, W.T.; Xia, W.; Rahmati, T.; Wolfe, M.S.; Selkoe, D.J. (2000). The Transmembrane Aspartates in Presenilin I and 2 are Obligatory for Gamma-secretase Activity and Amyloid B-protein Generation. Journal of Biological Chemistry, 275(5), 3173–3178.
Kluger, A.; Ferris, S.H.; Golomb, J.; Mittelman, M.S.; Reisberg, B. (1999). Neuropsychological Prediction of Decline to Dementia in Nondemented Elderly. Journal of Geriatric Psychiatry and Neurology, 12(4), 168–179.
Launer, L.J.; Andersen, K.; Dewey, M.E.; Letenneur, L.; Ott, A.; Amaducci, L.A.; Brayne, C.; Copeland, J.R.M.; Dartigues, J.E; Kragh-Sorensen, P.; Lobo, A.; Martinez-Lage, J.M.; Stijnen, T.; Hofman, A. (1999). Rates and Risk Factors for Dementia and Alzheimer’s Disease: Results from EURODERM Pooled Analyses. EURODERM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology, 52(1), 78–84.
Launer, L.J.; Ross, G.W.; Petrovich, H.; Masaki, K.; Foley, D.; White, L.R.; Havlik, R.J. (2000). Midlife Blood Pressure and Dementia: The Honolulu-Asia Aging Study. Neurobiology of Aging, 2t(1), 49–55.
LeBlanc, A.; Liu, H.; Goodyer, C.; Bergeron, C.; Hammond, J. (1999). Caspase-6 Role in Apoptosis of Human Neurons, Amyloidogenesis, and Alzheimer’s Disease. Journal of Biological Chemistry, 274(33), 23426–23436.
Leon, J.; Cheng, C.K.; Neumann, P.J. (1998). Alzheimer’s Disease Care: Costs and Potential Savings. Health Affairs (Millwood), 17(6), 206–216.
Lewis, J.; McGowan, E.; Rockwood, J.; Melrose, H.; Hacharaju, P.; Van Slegtenhorst, M.; Gwinn-Hardy, K.; Paul, M.M.; Baker, M.; Yu, X.; Duff, K.; Hardy, J.; Corral, A.; Lin, W.L.; Yen, S.H.; Dickson, D.W.; Davies, P.; Hutton, M. (2000). Neurofibrillary Tangles, Amyotrophy and Progressive Motor Disturbance in Mice Expressing Mutant (P301L) Tau Protein. Nature Genetics, 25(4), 402–405.
Li, Y.M.; Lai, M.T.; Xu, M.; Huang, Q.; DiMuzio-Mower, J.; Sardana, M.K.; Shi, X.P.; Yin, K.C.; Shafer, J.A.; Gardell, S.J. (2000). Presenilin I Is Linked with Gamma-secretase Activity in the Detergent Solubilized State. Proceedings of the National Academy of Sciences USA, 97(11), 6138–6143.
Lim, G.P.; Yang, F.; Chu, T.; Chen, P.; Beech, W.; Teter, B.; Tran, T.; Ubeda, O.; Ashe, K.H.; Frautschy, S.A.; Cole, G.M. (2000). lbuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer’s Disease. Journal of Neuroscience, 20(15), 5709–5714.
Lin, X.; Koelsch, G.; Wu, S.; Downs, D.; Dashti, A.; Tang, J. (2000). Human Aspartic Protease Memapsin 2 Cleaves the B-Secretase Site of Beta-amyloid Precursor Protein. Proceedings of the National Academy of Sciences USA, 97(4), 1456–1460.
Lindquist, I.; Liu, I. (2000). Expanding the Prion Model for the Yeast. Trends in Microbiology, 8(1), 3.
Lorenzo, A.; Yuan, M.; Zhang, Z.; Zhang, P.A.; Sturchler-Pierrat, C.; Staufenbiel, M.; Mautino, J.; SolVigo, E; Sommer, B.; Yankner, B.A. (2000). Amyloid 8 Interacts with the Amyloid Precursor Protein: A Potential Toxic Mechanism in Alzheimer’s Disease. Nature Neuroscience, 3(5), 460–464.
Maki, P.M.; Resnick, S.M. (2000). Longitudinal Effects of Estrogen Replacement Therapy on PET Cerebral Blood Flow and Cognition. Neurobiology of Aging, 21(2), 373–383.
Maki, P.M.; Zonderman, A.B.; Resnick, S.M. (2001). Enhanced Verbal Memory in Nondemented Elderly Women Receiving Hormone-Replacement Therapy. American Journal of Psychiatry, 158(2), 227–233.
Marson, D.; Harrell, L. (1999). Executive Dysfunction and Loss of Capacity to Consent to Medical Treatment in Patients with Alzheimer’s Disease. Seminars in Clinical Neuropsychiatry, 4(1), 41–49.
Masliah, E.; Rockenstein, E.; Veinbergs, I.; Mallory, M.; Hashimoto, M.; Takeda, A.; Sagara, Y.; Sisk, A.; Mucke, L. (2000). Dopaminergic Loss and Inclusion Body Formation in Alpha-synuclein Mice: Implications for Neurodegenerative Disorders. Science, 287(5456), 1265–1269.
Mattson, M.P.; Zhu, H.; Yu, J.; Kindy, M.S. (2000). Presenilin-I Mutation Increases Neuronal Vulnerability to Focal Ischemia in Vivo and to Hypoxia and Glucose Deprivation in Cell Culture: Involvement of Perturbed Calcium Homeostasis. Journal of Neuroscience, 20(4), 1358–1364.
Mayeux, R.; Tang, M.X.; Jacobs, D.M.; Manly, J.; Bell, K.; Merchant, C.; Small, S.A.; Stern, Y.; Wisniewski, H.M.; Mehta, P.D. (1999). Plasma Amyloid B-peptide 1–42 and Incipient Alzheimer’s Disease. Annals of Neurology, 46(3), 412–416.
Moceri, V.M.; Kukull, W.A.; Emanuel, I.; van Belle, G.; Larson, E.B. (2000). Early Life Risk Factors and the Development of Alzheimer’s Disease. Neurology, 54(2), 415–420.
Mulnard, R.A.; Cotman, C.W.; Kawas, C.; van Dyck, C.H.; Sano, M.; Doody, R.; Koss, E.; Pfeiffer, E.; Jin, S.; Gamst, A.; Grundman, M.; Thomas, R.; Thal, L.J. (2000). Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease: A Randomized Controlled Trial. Alzheimer’s Disease Cooperative Study. JAMA, 283(8), 1007–1015.
Murphy, D.D.; Rueter, S.M.; Trojanowski, J.Q.; Lee, V.M. (1999). Synucleins are Developmentally Expressed and Alpha-synuclein Regulates the Size of the Presynaptic Vesicular Pool in Primary Hippocampal Neurons. Proceedings of the National Academy of Sciences USA, 96(23), 13450–13455.
Naslund, J.; Haroutunian, V.; Mobs, R.; Davis, K.L.; Davies, P; Greengard, P.; Buxbaum, J.D. (2000). Correlation Between Elevated Levels of Amyloid Beta-peptide in the Brain and Cognitive Decline. JAMA, 283(12), 1571–1577.
Nicoll, J.A.; Mrak, R.E.; Graham, D.I.; Stewart, J.; Wilcock, G.; MacGowan, S.; Esiri, M.M.; Murray, L.S.; Dewar, D.; Love, S.; Moss, T.; Griffin, W.S. (2000). Association of Interleukin-I Gene Polymorphisms With Alzheimer’s Disease. Annals of Neurology, 47(3), 365–368.
Ory, M.G.; Hoffman, R.R.; Yee, J.L.; Tennstedt, S.; Schulz, R. (1999). Prevalence and Impact of Caregiving: A Detailed Comparison Between Dementia and Nondementia Caregivers. The Gerontologist, 39(2), 177–185.
Ostwald, S.K.; Hepburn, K.W.; Caron, W.; Burns, T.; Mantell, R. (1999). Reducing Caregiver Burden: A Randomized Psychoeducational Intervention for Caregivers of Persons with Dementia. The Gerontologist. 39(3), 299–309.
Paulsen, J.S.; Salmon, D.P.; Thal, L.J.; Romero, R.; Weisstein-Jenkins, C.; Galasko, D.; Hofstetter, C.R.; Thomas, R.; Grant, L; Jeste, D.V. (2000). Incidence of and Risk Factors for Hallucinations and Delusions in Patients with Probable AD. Neurology, 54(10), 1965–1971.
Perl, D.P.; Olanow, C.W.; Calne, D. (1998). Alzheimer’s Disease and Parkinson’s Disease: Distinct Entities or Extremes of a Spectrum of Neurodegeneration? Annals of Neurology, 44(3 Suppl 1), S19-S31.
Petersen, R.C.; Jack, C.R.; Xu, Y.C.; Waring, S.C.; O’Brien, P.C.; Smith, G.E.; Ivnik, R.J.; Tangalos, E.G.; Boeve, B.F.; Kokmen, E. (2000). Memory and MRI-based HippocampalVolumes in Aging and AD. Neurology, 54(3), 581–587.
Petrovitch, H.; White, L.R.; Izmirilian, G.; Ross, G.W.; Havlik, R.J.; Markesbery, W.; Nelson, J.; Davis, D.G.; Hardman, J.; Foley, D.J.; Launer, L.J. (2000). Midlife Blood Pressure and Neuritic Plaques, Neurofibrillary Tangles, and Brain Weight at Death: The HAAS. Honolulu-Asia Aging Study. Neurobiology of Aging, 21(1), 57–62.
Plassman, B.L.; Havlik, R.J.; Steffens, D.C.; Helms, M.J.; Newman, T.N.; Drosdick, D.; Phillips, C.; Gan, B.A.; Welsh-Bohmer, K.A.; Burke, J.R.; Guralnik, J.M.; Breitner, J.C. (2000). Documented Head Injury in Early Adulthood and Risk Factors of Alzheimer’s Disease and Other Dementias. Neurology, 55(8), 1158–1166.
Raber, J.; Wong, D.; Yu, G.Q.; Buttini, M.; Mahley, R.W.; Pitas, R.E.; Mucke, L. (2000). Apolipoprotein E and Cognitive Performance. Nature, 404(6776), 352–354.
Reiman, E.M.; Caselli, R.J.; Chen, K.; Alexander, G.E.; Bandy, D.; Frost, J. (2000). Functional Brain Imaging in Subjects at Genetic Risk for Alzheimer’s Disease. Presentation at the 7th International Conference on Alzheimer’s Disease and Related Disorders; Washington, D.C.; July 9–18, 2000. Neurobiology of Aging, 21 (1 S), S 141. Abstract no. 636.
Rogers, J.C.; Holm, M.B.; Burgio, L.D.; Granieri, E.; Hsu, C.; Hardin, J.M.; McDowell, B.J. (1999). Improving Morning Care Routines of Nursing Home Residents with Dementia. Journal of the American Geriatrics Society, 47(9), 1049–1057.
Satyal, S.H.; Schmidt, E.; Kitagawa, K.; Sondheimer, N.; Lindquist, S.; Kramer, J.M.; Morimoto, R.I. (2000). Polyglutarnine Aggregates Alter Protein Folding Homeostasis in Caenorhabditis Elegans. Proceedings of the National Academy of Sciences USA, 97(11), 5750–5755.
Saunders A.J.; Kim T.W.; Tanzi R.E. (1999). BACE Maps to Chromosome 11 and a BACE Homolog BACE2, Reside in the Obligate Down Syndrome Region of Chromosome 21. Science, 286, 1255–1256a.
Saxton, J.; Butters, M.A.; Shelton, C. (1999). Alcoholism, Dementia, and Alzheimer’s Disease: Neuropsychological Characteristics and Differential Diagnosis. St. Francis Journal of Medicine, 5(1), 72–77.
Schenk, D.; Barbour, R.; Dunn, W.; Gordon, G.; Grajeda, H.; Guido, T.; Hu, K.; Huang, J.; Johnson-Wood, K.; Khan, K.; Kholodenko, D.; Lee, M.; Liao, Z.; Lieberberg, L.; Motter, R.; Mutter, L.; Soriano, F.; Shopp, G.; Vasquez, N.; Vandevert, C.; Walker, S.; Wogulis, M.; Yednock, T.; Games, D.; Seubert, P. (1999). Immunization With Amyloid-8 Attenuates Alzheimer-disease-like Pathology in the PDAPP Mouse. Nature, 400(6740), 173–177.
Scott, WK.; Grubber, J.M.; Conneally, P.M.; Small, G.W.; Huletter, C.M.; Rosenberg, C.K.; Saunders, A.M.; Roses, A.D.; Haines, J.L.; Pericak-Vance, M.A. (2000). Fine Mapping of the Chromosome 12 Late-onset Alzheimer Disease Locus: Potential Genetic and Phenotypic Heterogeneity, American Journal of Human Genetics, 66(3), 922–932.
Shumaker, S.A.; Reboussin, B.A.; Espeland, M.A.; Rapp, S.R.; McBee, W.L.; Dailey, M.; Bowen, D.; Terrell, T.; Jones, B.N. (1998). The Women’s Health Initiative Memory Study (WHIMS): A Trial of the Effect of Estrogen Therapy in Preventing and Slowing the Progression of Dementia. Controlled Clinical Trials, 19(6), 604–621.
Sigurdsson, E.M.; Permanne, B.; Soto, C.; Wisniewski, T.; Frangione, B. (2000). In Vivo Reversal of Amyloid-8 Lesions in Rat Brain. Journal of Neuropathology and Experimental Neurology, 59(1), 11–17.
Silverman, J.M.; Smith, C.J.; Marin, D.B.; Birstein, S.; Mare, M.; Mobs, R.C.; Davis, K.L. (1999). Identifying Families With Likely Genetic Protective Factors Against Alzheimer Disease. American Journal of Human Genetics, 64(3), 832–838.
Sinha, S.; Anderson, J.P.; Barbour, R.; Basi, G.S.; Caccavello, R.; Davis, D.; Doan, M.; Dovey, H.F.; Frigon, N.; Hong, J.; Jacobson-Croak, K.; Jewett, N.; Keim, P.; Knops, J.; Lieberburg, L.; Power, M.; Tan, H.; Tatsuno, G.; Tung, J.; Schenk, D.; Seubert, P.; Suomensaari, S.M.; Wang, S.; Walker, D.; Zhao, J.; McConlogue L.; John V. (1999). Purification and Cloning of Amyloid Precursor Protein B-secretase fro. Human Brain. Nature, 402(6761), 537–540.
Skovronsky, D.M.; Zhang, B.; Kung, M.P.; Kung, H.F.; Trojanowski, J.Q.; Lee, V.M. (2000). In Vivo Detection of Amyloid Plaques in a Mouse Model of Alzheimer’s Disease. Proceedings of the National Academy of Sciences USA, 97(13), 7609–7614.
Small, G.W.; Ercoli, L.M.; Silverman, D.H.S.; Huang, S.C.; Komo, S.; Bookheimer, S.Y.; Lavretsky, H.; Miller, K.; Siddarth, P.; Rasgon, N.L.; Mazziotta, J.C.; Saxena, S.; Wu, H.M.; Mega, M.S.; Cummings, J.L.; Saunders, A.M.; Pericak-Vance, M.A.; Roses, A.D.; Barrio, J.R.; Phelps, M.E. (2000). Cerebral Metabolic and Cognitive Decline in Persons at Genetic Risk for Alzheimer’s Disease. Proceedings of the National Academy of Sciences USA, 97(11), 6037–6042.
Smith, D.E.; Roberts, J.; Gage, F.H.; Tuzynski, M.H. (1999). Age-associated Neuronal Atrophy Occurs in the Primate Brain and is Reversible by Growth Factor Gene Therapy. Proceedings of the National Academy of Sciences USA, 96(25), 10893–10898.
Soto, C.; Kascsak, R.J.; Sabodo, G.P.; Aucouturier, P.; Wisniewski, T.; Prelli, F.; Kascsak, R.; Mendez, E.; Harris, D.A.; Ironside, J.; Tagliavini, F.; Carp, R.I.; Frangione, B. (2000). Reversion of Prion Protein Conformational Changes by Synthetic b-sheet Breaker Peptides. Lancet, 355(9199), 192–197.
Strittmatter, W.J.; Saunders, A.M.; Schmechel, D.; Pericak-Vance, M.; Enghild, J.; Salvesen, G.S.; Roses, A.D. (1993). Apolipoprotein E: High-Avidity Binding to Beta-Amyloid and Increased Frequency of Type 4 Allele in Late-onset Familial Alzheimer Disease. Proceedings of the National Academy of Sciences USA, 90(5), 1977–1981.
Sultzer, D.L. (1996). Behavioral Syndrome in Dementia: Neuroimaging Insights. Seminars in Clinical Neuropsychiatry, 1(4), 261–271.
Sultzer, D.L. (1999). Depression, Delusions, and Agitation in Alzheimer’s Disease: Diagnosis and Treatment. Postgraduate Medicine (Special Report: Practical Alzheimer’s Disease Management), 19–26.
Tang, M.X.; Stem, Y.; Marder, K.; Bell, K.; Gurland, B.; Lantigua, R.; Andrews, H.; Feng, L.; Tycko, B.; Mayeux, R. (1998). The APOE-epsilon4 Allele and the Risk of Alzheimer Disease Among African Americans, Whites, and Hispanics. JAMA, 279(10), 751–755.
Tanzi, R.E. (1999). A Genetic Dichotomy Model for the Inheritance of Alzheimer’s Disease and Common Age-related Disorders. Journal of Clinical Investigation, 104(9), 1175–1179.
Tarlow, B.; Mahoney, D. (2000). The Cost of Recruiting Alzheimer’s Disease Caregivers for Research. Journal of Aging and Health, 12(41), 490–510.
Teri, L.; Logsdon, R.G.; Peskind, E.; Raskind, M.; Weiner, M.F.; Tractenberg, R.E.; Foster, N.L.; Schneider, L.S.; Sano, M.; Whitehouse, P.; Mellow, A.M.; Auchus, A.P.; Grundman, M.; Thomas, R.G.; Schafer, K.; Thal, L.J. (2000). Treatment of Agitation in AD: A Randomized, Placebo-Controlled Clinical Trial. Neurology, 14;55 (9), 1271–1278.
Tolar, M.; Keller, J.N.; Chan, S.; Mattson, M.P.; Marques, M.A.; Crutcher, K.A. (1999). Truncated Apolipoprotein E (ApoE) Causes Increased Intracellular Calcium and May Mediate ApoE Neurotoxicity. Journal of Neuroscience, 19(16), 7100–7110.
Troy, C.M.; Rabacchi, S.A.; Friedman, W.J.; Frappier, T.F.; Brown, K.; Shelanski, M.L. (2000). Caspase-2 Mediates Neuronal Cell Death Induced by B-amyloid. Journal of NeuroScience, 20(4), 1386–1392.
Uboga, N.V.; Price, J.L. (2000). Formation of Diffuse and Fibrillar Tangles in Aging and Early Alzheimer’s Disease. Neurobiology of Aging, 21(1), 1–10.
Van Praag, H.; Christie, B.R.; Sejnowski, T.J.; Gage, F.H. (1999). Running Enhances Neurogenesis, Learning and Long-term Potentiation in Mice. Proceedings of the National Academy of Sciences USA, 96(23), 13427–13431.
Vassar, R.; Bennett, B.Q.; Babu-Khan, S.; Kahn, S.; Mendiaz, E.A.; Denis, P.; Teplow, D.B.; Ross, S.; Amarante, R.; Locloff, R.; Luo, Y.; Fisher, S.; Fuller, J.; Edenson, S.; Lile, J.; Jarosinski, M.A.; Biere, A.L.; Curran, E.; Burgess, T.; Louis, J.C.; Collins, F.; Treanor, J.; Rogers, G.; Citron, M, (1999). b-Secretase Cleavage of Alzheimer’s Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE. Science, 286(5440), 735–741.
Vekrellis, K.; Ye, Z.; Qiu, W.Q.; Walsh, D.; Hartley, D.; Chesneua, V.; Rosner, M.R.; Selkoe, D.J. (2000). Neurons Regulate Extracellular Levels of Amyloid B-proteinVia Proteolysis by Insulin-Degrading Enzyme. Journal of NeuroScience, 20(5), 1657–1665.
Vidal, R.; Frangione, B.; Rostagno, A.; Mead, S.; Revesz, T.; Plant, G.; Ghiso, J. (1999). A Stopcodon Mutation in the BRI Gene Associated With Familial British Dementia. Nature, 399(6738), 776–781.
Vidal, R.; Révész, T.; Rostagno, A.; Kim, E.; Holton, J.L.; Bek, T.; Bojsen-Moller, M.; Braendgaard, H.; Plant, G.; Ghiso, J.; Frangione, B. (2000). A Decamer Duplication in the 3’ Region of the BRI Gene Originates an Amyloid Peptide That is Associated With Dementia in a Danish Kindred. Proceedings of the National Academy of Sciences USA. 97(9), 4920–4925.
Wagner, J.P.; Black, LB.; DeCicco-Bloom, E. (1999). Stimulation of Neonatal and Adult Brain Neurogenesis by Subcutaneous Injection of Basic Fibroblast Growth Factor. Journal of Neuroscience, 19(14), 6006–6016.
Wang, P.N.; Liao, S.Q.; Liu, R.S.; Liu, C.Y.; Chao, H.T.; Lu, S.R.; Yu, H.Y.; Wang, S.J.; Liu, H.C. (2000). Effects of Estrogen on Cognition, Mood, and Cerebral Blood Flow in AD: A Controlled Study. Neurology, 54(11), 2061–2066.
Warwick Daw, E.W.; Payami, H.; Nemens, E.J.; Nochlin, D.; Bird, T.D.; Schellenberg, G.D.; Wijsman, E.M. (2000). The Number of Trait Loci in Late-onset Alzheimer Disease. American Journal of Human Genetics, 66(1), 196–204.
Webster, S.D.; Yang, A.J.; Margol, L.; GarzonRodriguez, W.; Glabe, C.G.; Tenner, A.J. (2000). Complement Component C I q Modulates the Phagocytosis of Abeta by Microglia. Experimental Neurology, 161(1), 127–138.
Weiner, H.L.; Lemere, C.A.; Maron, R.; Spooner, E.T.; Grenfell, T.J.; Mori, C.; Issazadeh, S.; Hancock, W.W.; Selkoe, D.J. (2000). Nasal Administration of Amyloid-B Peptide Decreases Cerebral Amyloid Burden in a Mouse Model of Alzheimer’s Disease. Annals of Neurology, 48(4), 567–579.
Whall, A.L.; Black, M.E.A.; Yankou, D.J.; Groh, D.J.; Kupferschmid, B.J.; Foster, N.L.; Little, R. (1999). Nurse Aides’ Identification of Onset and Level of Agitation in Late Stage Dementia Patients. American Journal of Alzheimer’s Disease, 14, 202–206.
Wolfe, M.S.; De Los Angeles, J.; Miller, D.D.; Xia, W.; Selkoe, D.J. (1999). Are Presenilins Intramembrane-cleaving Proteases? Implications for the Molecular Mechanism of Alzheimer’s Disease. Biochemistry, 38(35), 11223–11230.
Yan, R.; Bienkowski, M.J.; Shuck, M.E.; Miao, H.; Tory, M.C.; Pauley, A.M.; Brashier, J.R.; Stratman, N.C.; Mathews, W.R.; Buhl, A.E.; Carter, D.B.; Tomasselli, A.G.; Parodi, L.A.; Heinrikson, R.L.; Gurney, M.E. (1999). Membrane-anchored Aspartyl Protease with Alzheimer’s Disease b-secretase Activity. Nature, 402(6761), 533–537.
Yang, E.; Ueda, K.; Chen, P.P.; Ashe, K.H.; Cole, G.M. (2000). Plaque-associated Alpha-synuclein (NACP) Pathology in AgedTransgenic Mice Expressing Amyloid Precursor Protein. Brain Research, 853(2), 381–383.
Zhu, H.; Fu, W.; Mattson, MY, (2000). The Catalytic Subunit of Telomerase Protects Neurons Against Amyloid Beta-peptide- induced Apoptosis. Journal of Neurochemistry, 75(1), 117–124.
Zhu, H.; Guo, Q.; Mattson, M.P. (1999). Dietary Restriction Protects Hippocampal Neurons Against the Death-promoting Action of a Presenilin-1 Mutation. Brain Research, 842(1), 224–229.
Rights and permissions
About this article
Cite this article
Progress report on Alzheimer’s disease: Taking the next steps. Ageing Int. 26, 38–125 (2000). https://doi.org/10.1007/s12126-000-1003-0
Issue Date:
DOI: https://doi.org/10.1007/s12126-000-1003-0